Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

24,871 Parents/carers responded to an SMS about their child’s health a
few days after their influenza vaccinations.

93.9%
reported no adverse events

93.9%
reported no adverse events

6.1%
reported any adverse
event, including...

0.8%
who reported taking their child
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

1,526 parents/carers reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived. These symptoms are also common in young children for other reasons (such as viral infection) and may not be related to vaccination.

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

14,024 Parents/carers responded to an SMS about their child’s health a
few days after their influenza vaccinations.

93.6%
reported no adverse events

93.6%
reported no adverse events

6.4%
reported any adverse
event, including...

0.6%
who reported taking their child
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

891 parents/carers reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived. These symptoms are also common in young children for other reasons (such as viral infection) and may not be related to vaccination.

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

37,710 Parents/carers responded to an SMS about their child’s health a
few days after their influenza vaccinations.

95%
reported no adverse events

95%
reported no adverse events

5%
reported any adverse
event, including...

0.5%
who reported taking their child
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

 

1,903 parents/carers reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived. These symptoms are also common in young children for other reasons (such as viral infection) and may not be related to vaccination.

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

89,965 Adults responded to an SMS about their health a
few days after their influenza vaccinations.

93.9%
reported no adverse events

93.9%
reported no adverse events

6.1%
reported any adverse
event, including...

0.3%
who reported going
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

5,444 Adults reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived.

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

69,996 Seniors responded to an SMS about their health a
few days after their influenza vaccinations.

93.9%
reported no adverse events

93.9%
reported no adverse events

6.1%
reported any adverse
event, including...

0.3%
who reported going
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

4,272 Senoirs reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived.

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019 and concluded on 1st September 2019. More than 200,000 participants have provided feedback via SMS following their vaccination. The current reported event rates are consistent with existing data on influenza vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

Last updated 13/12/2019

3,718 Women responded to an SMS about their health a
few days after their influenza vaccinations.

95.5%
reported no adverse events

95.5%
reported no adverse events

5.5%
reported any adverse
event, including...

0.5%
who reported going
to a doctor or emergency
department in the days after
vaccination.

The adverse events they reported were similar to the types of adverse events reported overall

 

204 Women reported one or more adverse events.
The most commonly reported were:

These symptoms are known to occur after vaccination. They are generally mild and short-lived.